The new GDP rules published in Russia last year have been valid since 1 March 2017. They do of course apply to companies in Russia, but also pharmaceutical companies distributing to Russia should be aware of the new rules on storage and transportation. Companies operating in Russia are now also responsible for ensuring that any contract warehouses and other third party services do meet the same requirements.
So with these new rules which are similar to the EU and PIC/S GDP guidelines, pharmaceutical manufacturers, distributors and warehouses should check their existing quality systems and implement or provide for example:
Initial and on-going training for all employees involved in GDP
GDP compliant quality system and standard operating procedures in place
GDP compliant documentation, record-keeping and reporting
Separate storage areas for counterfeit medicines
Appointing a person being responsible for implementing and maintaining the quality system and monitoring its compliance and efficiency
Monitoring compliance of third party logistic providers and warehouses (including audits)